Cystic Fibrosis Survival Rates: Understanding Prognosis & Progress

According to the Cystic Fibrosis Foundation, the median predicted survival for people with cystic fibrosis born in 2019 was 50.8 years. This means that half of the people with CF born in 2019 are predicted to live at least 50.8 years, while the other half will live less than that. However, survival rates have been steadily increasing over time, thanks to improvements in diagnosis, treatment, and care. In 1990, the median predicted survival for people with CF was only 31 years. The increase in survival rate is due to a number of factors, including:

Early diagnosis: CF is now typically diagnosed through newborn screening, which allows treatment to begin early, before irreversible damage can occur to the lungs and other organs.

Advances in treatment: There have been significant advances in the treatment of CF, including the development of new medications and therapies that target the underlying causes of the disease. These treatments have helped to improve lung function, reduce infections, and slow the progression of the disease.

Improved overall care: People with CF now have access to comprehensive care that includes regular monitoring, physical therapy, nutritional support, and psychological counseling. This comprehensive approach to care has helped to improve the overall quality of life for people with CF and has also contributed to increased survival rates.